Crude Oil Moves Lower; Neogen Posts Downbeat Results
Portfolio Pulse from Lisa Levin
U.S. stocks traded higher with the Dow Jones gaining around 175 points. Neogen Corporation reported weaker-than-expected results for its first quarter. SMX shares shot up 62% after the company announced it secured a majority stake in True Gold Consortium. Shares of Intrusion Inc. and Startek, Inc. also rose significantly. Akero Therapeutics, Athersys, Inc., and Ventyx Biosciences saw their shares drop after reporting disappointing results or news.
October 10, 2023 | 6:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akero Therapeutics shares dropped 62% after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin, which could negatively impact its stock price.
Akero Therapeutics' disappointing results from its Phase 2b SYMMETRY study could decrease investor confidence, potentially driving the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Neogen Corporation reported weaker-than-expected results for its first quarter, which could negatively impact its stock price.
Neogen's weaker-than-expected Q1 results could lead to a decrease in investor confidence, potentially driving the stock price down.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SMX shares shot up 62% after the company announced it secured a majority stake in True Gold Consortium, which could positively impact its stock price.
SMX's acquisition of a majority stake in True Gold Consortium could increase investor confidence, potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100